trial summary · NCT07343297
Ask Questions About Clinical Trials
Ask Questions About Clinical Trials (ASQ - CT): An Implementation Trial of a Communication Intervention to Improve Patient-Provider Communication About Clinical Trials and Provider Invitations to Clinical Trials
Trial record from the TrialBase DB dataset, status RECRUITING, condition Oncology, sponsored by Barbara Ann Karmanos Cancer Institute. Facts below are exported values from the current release, not inferred or edited prose.
Summary
The brief summary is the registry's published description, capped for length. Field definitions, types, and provenance rules are in the data dictionary.
The overall goal of this study is to assess the implementation of the Ask Questions about Clinical Trials (ASQ-CT) brochure, a patient-focused communication tool previously demonstrated to improve patient-provider communication about clinical trials. Participants will be given the ASQ-CT brochure at Time 1 (baseline) and participants will complete a questionnaire at three timepoints, baseline (Time 1), Pre-Research Visit (Time 2), and Post-Research Visit (Time 3).
Source record: https://clinicaltrials.gov/study/NCT07343297
Facts
| registry id | NCT07343297 |
|---|---|
| primary registry | clinicaltrials-gov |
| recruitment status | RECRUITING |
| phase | not reported |
| study type | INTERVENTIONAL |
| lead condition | Oncology |
| sponsor | Barbara Ann Karmanos Cancer Institute |
| sponsor class | OTHER |
| enrollment | 293 |
| start date | 2026-12-30 |
| primary completion | 2027-12-30 |
| completion | 2028-04-05 |
| results posted | not reported |
Conditions
- Oncology
- Cardiac Disease
- Neurologic Disorder
Interventions
- Ask Questions about Clinical Trials brochure
Countries
- United States
Intervention types: BEHAVIORAL
Work with this record
- Field definitions
Types, scope, and provenance rules for every exported field.
- REST API
Query the same gate-backed records programmatically.
- Evaluation sample
Download a bounded slice before buying.
- $29 API Pass
Seven days of REST and MCP access; credited toward the licence.